nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Estramustine—prostate cancer	0.697	1	CiPCiCtD
Carmustine—CYP1A2—Flutamide—prostate cancer	0.0363	0.347	CbGbCtD
Carmustine—CYP1A2—Estrone—prostate cancer	0.0262	0.251	CbGbCtD
Carmustine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0172	0.164	CbGbCtD
Carmustine—CYP1A2—Estradiol—prostate cancer	0.0151	0.144	CbGbCtD
Carmustine—CYP1A2—Etoposide—prostate cancer	0.00984	0.0941	CbGbCtD
Carmustine—GSR—prostate gland—prostate cancer	0.00254	0.177	CbGeAlD
Carmustine—CYP1A2—urine—prostate cancer	0.00241	0.168	CbGeAlD
Carmustine—GSR—seminal vesicle—prostate cancer	0.00215	0.15	CbGeAlD
Carmustine—GSR—renal system—prostate cancer	0.00173	0.121	CbGeAlD
Carmustine—GSR—urethra—prostate cancer	0.0017	0.118	CbGeAlD
Carmustine—GSR—bone marrow—prostate cancer	0.00131	0.0912	CbGeAlD
Carmustine—GSR—testis—prostate cancer	0.00112	0.078	CbGeAlD
Carmustine—Lomustine—CYP3A4—prostate cancer	0.000845	1	CrCbGaD
Carmustine—GSR—lymph node—prostate cancer	0.000813	0.0565	CbGeAlD
Carmustine—CYP1A2—renal system—prostate cancer	0.00059	0.041	CbGeAlD
Carmustine—Alopecia—Prednisone—prostate cancer	3.34e-05	0.000302	CcSEcCtD
Carmustine—Hyperglycaemia—Epirubicin—prostate cancer	3.33e-05	0.000301	CcSEcCtD
Carmustine—Somnolence—Etoposide—prostate cancer	3.33e-05	0.000301	CcSEcCtD
Carmustine—Hypersensitivity—Mitoxantrone—prostate cancer	3.32e-05	0.0003	CcSEcCtD
Carmustine—Pneumonia—Epirubicin—prostate cancer	3.31e-05	0.0003	CcSEcCtD
Carmustine—Mental disorder—Prednisone—prostate cancer	3.31e-05	0.000299	CcSEcCtD
Carmustine—Diarrhoea—Estradiol—prostate cancer	3.31e-05	0.000299	CcSEcCtD
Carmustine—Leukopenia—Capecitabine—prostate cancer	3.31e-05	0.000299	CcSEcCtD
Carmustine—Convulsion—Docetaxel—prostate cancer	3.31e-05	0.000299	CcSEcCtD
Carmustine—Hypertension—Docetaxel—prostate cancer	3.29e-05	0.000298	CcSEcCtD
Carmustine—Malnutrition—Prednisone—prostate cancer	3.29e-05	0.000298	CcSEcCtD
Carmustine—Erythema—Prednisone—prostate cancer	3.29e-05	0.000298	CcSEcCtD
Carmustine—Decreased appetite—Etoposide—prostate cancer	3.26e-05	0.000295	CcSEcCtD
Carmustine—Chest pain—Docetaxel—prostate cancer	3.25e-05	0.000294	CcSEcCtD
Carmustine—Myalgia—Docetaxel—prostate cancer	3.25e-05	0.000294	CcSEcCtD
Carmustine—Pancytopenia—Doxorubicin—prostate cancer	3.25e-05	0.000294	CcSEcCtD
Carmustine—Renal failure—Epirubicin—prostate cancer	3.24e-05	0.000293	CcSEcCtD
Carmustine—Gastrointestinal disorder—Etoposide—prostate cancer	3.24e-05	0.000293	CcSEcCtD
Carmustine—Asthenia—Mitoxantrone—prostate cancer	3.23e-05	0.000292	CcSEcCtD
Carmustine—Neuropathy peripheral—Epirubicin—prostate cancer	3.23e-05	0.000292	CcSEcCtD
Carmustine—Stomatitis—Epirubicin—prostate cancer	3.21e-05	0.00029	CcSEcCtD
Carmustine—Pain—Etoposide—prostate cancer	3.2e-05	0.00029	CcSEcCtD
Carmustine—Constipation—Etoposide—prostate cancer	3.2e-05	0.00029	CcSEcCtD
Carmustine—Urinary tract infection—Epirubicin—prostate cancer	3.2e-05	0.000289	CcSEcCtD
Carmustine—Dizziness—Estradiol—prostate cancer	3.2e-05	0.000289	CcSEcCtD
Carmustine—Neutropenia—Doxorubicin—prostate cancer	3.2e-05	0.000289	CcSEcCtD
Carmustine—Hypertension—Capecitabine—prostate cancer	3.19e-05	0.000288	CcSEcCtD
Carmustine—Chest pain—Capecitabine—prostate cancer	3.15e-05	0.000284	CcSEcCtD
Carmustine—Myalgia—Capecitabine—prostate cancer	3.15e-05	0.000284	CcSEcCtD
Carmustine—Confusional state—Docetaxel—prostate cancer	3.14e-05	0.000284	CcSEcCtD
Carmustine—Anxiety—Capecitabine—prostate cancer	3.13e-05	0.000283	CcSEcCtD
Carmustine—Oedema—Docetaxel—prostate cancer	3.11e-05	0.000282	CcSEcCtD
Carmustine—Vision blurred—Prednisone—prostate cancer	3.1e-05	0.00028	CcSEcCtD
Carmustine—Infection—Docetaxel—prostate cancer	3.09e-05	0.00028	CcSEcCtD
Carmustine—Feeling abnormal—Etoposide—prostate cancer	3.09e-05	0.000279	CcSEcCtD
Carmustine—Hyperglycaemia—Doxorubicin—prostate cancer	3.08e-05	0.000279	CcSEcCtD
Carmustine—Diarrhoea—Mitoxantrone—prostate cancer	3.08e-05	0.000279	CcSEcCtD
Carmustine—Vomiting—Estradiol—prostate cancer	3.07e-05	0.000278	CcSEcCtD
Carmustine—Pneumonia—Doxorubicin—prostate cancer	3.07e-05	0.000277	CcSEcCtD
Carmustine—Gastrointestinal pain—Etoposide—prostate cancer	3.06e-05	0.000277	CcSEcCtD
Carmustine—Thrombocytopenia—Docetaxel—prostate cancer	3.05e-05	0.000276	CcSEcCtD
Carmustine—Rash—Estradiol—prostate cancer	3.05e-05	0.000276	CcSEcCtD
Carmustine—Dermatitis—Estradiol—prostate cancer	3.05e-05	0.000275	CcSEcCtD
Carmustine—Anaemia—Prednisone—prostate cancer	3.04e-05	0.000275	CcSEcCtD
Carmustine—Confusional state—Capecitabine—prostate cancer	3.04e-05	0.000275	CcSEcCtD
Carmustine—Tachycardia—Docetaxel—prostate cancer	3.04e-05	0.000275	CcSEcCtD
Carmustine—Headache—Estradiol—prostate cancer	3.03e-05	0.000274	CcSEcCtD
Carmustine—Agitation—Prednisone—prostate cancer	3.02e-05	0.000273	CcSEcCtD
Carmustine—Oedema—Capecitabine—prostate cancer	3.02e-05	0.000273	CcSEcCtD
Carmustine—GSR—Metabolism—AKR1C3—prostate cancer	3.01e-05	0.000416	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—SULT1A1—prostate cancer	3.01e-05	0.000415	CbGpPWpGaD
Carmustine—Renal failure—Doxorubicin—prostate cancer	3e-05	0.000271	CcSEcCtD
Carmustine—Infection—Capecitabine—prostate cancer	3e-05	0.000271	CcSEcCtD
Carmustine—GSR—Metabolism—PRKACB—prostate cancer	2.99e-05	0.000413	CbGpPWpGaD
Carmustine—Neuropathy peripheral—Doxorubicin—prostate cancer	2.99e-05	0.00027	CcSEcCtD
Carmustine—Haemoglobin—Epirubicin—prostate cancer	2.97e-05	0.000269	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—prostate cancer	2.97e-05	0.000269	CcSEcCtD
Carmustine—Anorexia—Docetaxel—prostate cancer	2.97e-05	0.000268	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GGT1—prostate cancer	2.97e-05	0.00041	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—SULT1A1—prostate cancer	2.96e-05	0.00041	CbGpPWpGaD
Carmustine—Abdominal pain—Etoposide—prostate cancer	2.96e-05	0.000268	CcSEcCtD
Carmustine—Body temperature increased—Etoposide—prostate cancer	2.96e-05	0.000268	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—prostate cancer	2.96e-05	0.000268	CcSEcCtD
Carmustine—GSR—Metabolism—CYP17A1—prostate cancer	2.96e-05	0.000409	CbGpPWpGaD
Carmustine—Haemorrhage—Epirubicin—prostate cancer	2.96e-05	0.000267	CcSEcCtD
Carmustine—Thrombocytopenia—Capecitabine—prostate cancer	2.95e-05	0.000267	CcSEcCtD
Carmustine—Tachycardia—Capecitabine—prostate cancer	2.94e-05	0.000266	CcSEcCtD
Carmustine—Hypoaesthesia—Epirubicin—prostate cancer	2.94e-05	0.000266	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTA1—prostate cancer	2.94e-05	0.000406	CbGpPWpGaD
Carmustine—Oedema peripheral—Epirubicin—prostate cancer	2.91e-05	0.000263	CcSEcCtD
Carmustine—Hypotension—Docetaxel—prostate cancer	2.91e-05	0.000263	CcSEcCtD
Carmustine—Connective tissue disorder—Epirubicin—prostate cancer	2.91e-05	0.000263	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTO1—prostate cancer	2.9e-05	0.000401	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—NAT2—prostate cancer	2.9e-05	0.000401	CbGpPWpGaD
Carmustine—Anorexia—Capecitabine—prostate cancer	2.87e-05	0.00026	CcSEcCtD
Carmustine—Nausea—Estradiol—prostate cancer	2.87e-05	0.00026	CcSEcCtD
Carmustine—Vomiting—Mitoxantrone—prostate cancer	2.86e-05	0.000259	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—NAT2—prostate cancer	2.86e-05	0.000396	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTO1—prostate cancer	2.86e-05	0.000396	CbGpPWpGaD
Carmustine—Convulsion—Prednisone—prostate cancer	2.85e-05	0.000258	CcSEcCtD
Carmustine—Visual impairment—Epirubicin—prostate cancer	2.85e-05	0.000258	CcSEcCtD
Carmustine—Hypertension—Prednisone—prostate cancer	2.84e-05	0.000257	CcSEcCtD
Carmustine—Rash—Mitoxantrone—prostate cancer	2.84e-05	0.000257	CcSEcCtD
Carmustine—Dermatitis—Mitoxantrone—prostate cancer	2.84e-05	0.000257	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.84e-05	0.000257	CcSEcCtD
Carmustine—Headache—Mitoxantrone—prostate cancer	2.82e-05	0.000255	CcSEcCtD
Carmustine—GSR—Metabolism—NCOA2—prostate cancer	2.82e-05	0.00039	CbGpPWpGaD
Carmustine—Hypotension—Capecitabine—prostate cancer	2.82e-05	0.000255	CcSEcCtD
Carmustine—Insomnia—Docetaxel—prostate cancer	2.82e-05	0.000255	CcSEcCtD
Carmustine—Myalgia—Prednisone—prostate cancer	2.8e-05	0.000253	CcSEcCtD
Carmustine—Paraesthesia—Docetaxel—prostate cancer	2.8e-05	0.000253	CcSEcCtD
Carmustine—Anxiety—Prednisone—prostate cancer	2.79e-05	0.000252	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP2C18—prostate cancer	2.78e-05	0.000385	CbGpPWpGaD
Carmustine—Dyspnoea—Docetaxel—prostate cancer	2.78e-05	0.000251	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—TP53—prostate cancer	2.77e-05	0.000383	CbGpPWpGaD
Carmustine—Somnolence—Docetaxel—prostate cancer	2.77e-05	0.00025	CcSEcCtD
Carmustine—Eye disorder—Epirubicin—prostate cancer	2.76e-05	0.00025	CcSEcCtD
Carmustine—Hypersensitivity—Etoposide—prostate cancer	2.76e-05	0.00025	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—prostate cancer	2.75e-05	0.000249	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.75e-05	0.000248	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2C18—prostate cancer	2.74e-05	0.000379	CbGpPWpGaD
Carmustine—Flushing—Epirubicin—prostate cancer	2.74e-05	0.000248	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—prostate cancer	2.74e-05	0.000247	CcSEcCtD
Carmustine—Insomnia—Capecitabine—prostate cancer	2.73e-05	0.000247	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—prostate cancer	2.72e-05	0.000246	CcSEcCtD
Carmustine—Paraesthesia—Capecitabine—prostate cancer	2.71e-05	0.000245	CcSEcCtD
Carmustine—Decreased appetite—Docetaxel—prostate cancer	2.71e-05	0.000245	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—prostate cancer	2.71e-05	0.000374	CbGpPWpGaD
Carmustine—Oedema peripheral—Doxorubicin—prostate cancer	2.7e-05	0.000244	CcSEcCtD
Carmustine—GSR—Metabolism—SLC5A5—prostate cancer	2.69e-05	0.000372	CbGpPWpGaD
Carmustine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.69e-05	0.000243	CcSEcCtD
Carmustine—Asthenia—Etoposide—prostate cancer	2.69e-05	0.000243	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—prostate cancer	2.69e-05	0.000243	CcSEcCtD
Carmustine—Dyspnoea—Capecitabine—prostate cancer	2.69e-05	0.000243	CcSEcCtD
Carmustine—Oedema—Prednisone—prostate cancer	2.69e-05	0.000243	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—COMT—prostate cancer	2.68e-05	0.00037	CbGpPWpGaD
Carmustine—Nausea—Mitoxantrone—prostate cancer	2.68e-05	0.000242	CcSEcCtD
Carmustine—Infection—Prednisone—prostate cancer	2.67e-05	0.000241	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTP1—prostate cancer	2.67e-05	0.000369	CbGpPWpGaD
Carmustine—Pain—Docetaxel—prostate cancer	2.66e-05	0.000241	CcSEcCtD
Carmustine—Constipation—Docetaxel—prostate cancer	2.66e-05	0.000241	CcSEcCtD
Carmustine—Arrhythmia—Epirubicin—prostate cancer	2.64e-05	0.000239	CcSEcCtD
Carmustine—Visual impairment—Doxorubicin—prostate cancer	2.64e-05	0.000238	CcSEcCtD
Carmustine—GSR—Metabolism—CYP2E1—prostate cancer	2.63e-05	0.000363	CbGpPWpGaD
Carmustine—Tachycardia—Prednisone—prostate cancer	2.62e-05	0.000237	CcSEcCtD
Carmustine—Decreased appetite—Capecitabine—prostate cancer	2.62e-05	0.000237	CcSEcCtD
Carmustine—Alopecia—Epirubicin—prostate cancer	2.61e-05	0.000236	CcSEcCtD
Carmustine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.6e-05	0.000235	CcSEcCtD
Carmustine—GSR—Metabolism—NQO1—prostate cancer	2.6e-05	0.000359	CbGpPWpGaD
Carmustine—Mental disorder—Epirubicin—prostate cancer	2.59e-05	0.000234	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—SULT2A1—prostate cancer	2.59e-05	0.000358	CbGpPWpGaD
Carmustine—Constipation—Capecitabine—prostate cancer	2.58e-05	0.000233	CcSEcCtD
Carmustine—Pain—Capecitabine—prostate cancer	2.58e-05	0.000233	CcSEcCtD
Carmustine—Erythema—Epirubicin—prostate cancer	2.57e-05	0.000233	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—prostate cancer	2.57e-05	0.000233	CcSEcCtD
Carmustine—Feeling abnormal—Docetaxel—prostate cancer	2.57e-05	0.000232	CcSEcCtD
Carmustine—Diarrhoea—Etoposide—prostate cancer	2.56e-05	0.000232	CcSEcCtD
Carmustine—GSR—Metabolism—TH—prostate cancer	2.56e-05	0.000354	CbGpPWpGaD
Carmustine—Anorexia—Prednisone—prostate cancer	2.56e-05	0.000231	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	2.56e-05	0.000354	CbGpPWpGaD
Carmustine—Eye disorder—Doxorubicin—prostate cancer	2.56e-05	0.000231	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—SULT2A1—prostate cancer	2.55e-05	0.000353	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Docetaxel—prostate cancer	2.55e-05	0.00023	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—IL6—prostate cancer	2.54e-05	0.000351	CbGpPWpGaD
Carmustine—Flushing—Doxorubicin—prostate cancer	2.54e-05	0.00023	CcSEcCtD
Carmustine—GSR—Metabolism—CYP3A4—prostate cancer	2.53e-05	0.00035	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP1B1—prostate cancer	2.49e-05	0.000344	CbGpPWpGaD
Carmustine—Back pain—Epirubicin—prostate cancer	2.49e-05	0.000225	CcSEcCtD
Carmustine—Feeling abnormal—Capecitabine—prostate cancer	2.48e-05	0.000225	CcSEcCtD
Carmustine—Dizziness—Etoposide—prostate cancer	2.48e-05	0.000224	CcSEcCtD
Carmustine—Gastrointestinal pain—Capecitabine—prostate cancer	2.47e-05	0.000223	CcSEcCtD
Carmustine—Abdominal pain—Docetaxel—prostate cancer	2.46e-05	0.000223	CcSEcCtD
Carmustine—Body temperature increased—Docetaxel—prostate cancer	2.46e-05	0.000223	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	2.45e-05	0.000339	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	2.45e-05	0.000339	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTM1—prostate cancer	2.45e-05	0.000339	CbGpPWpGaD
Carmustine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.45e-05	0.000221	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—prostate cancer	2.44e-05	0.000221	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—GPX3—prostate cancer	2.43e-05	0.000336	CbGpPWpGaD
Carmustine—Insomnia—Prednisone—prostate cancer	2.43e-05	0.00022	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—prostate cancer	2.43e-05	0.000219	CcSEcCtD
Carmustine—Alopecia—Doxorubicin—prostate cancer	2.42e-05	0.000219	CcSEcCtD
Carmustine—GSR—Metabolism—GGT1—prostate cancer	2.41e-05	0.000334	CbGpPWpGaD
Carmustine—Paraesthesia—Prednisone—prostate cancer	2.41e-05	0.000218	CcSEcCtD
Carmustine—CYP1A2—Tryptophan metabolism—MDM2—prostate cancer	2.41e-05	0.000333	CbGpPWpGaD
Carmustine—Mental disorder—Doxorubicin—prostate cancer	2.4e-05	0.000217	CcSEcCtD
Carmustine—Abdominal pain—Capecitabine—prostate cancer	2.38e-05	0.000216	CcSEcCtD
Carmustine—Body temperature increased—Capecitabine—prostate cancer	2.38e-05	0.000216	CcSEcCtD
Carmustine—Vomiting—Etoposide—prostate cancer	2.38e-05	0.000215	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—prostate cancer	2.38e-05	0.000215	CcSEcCtD
Carmustine—Erythema—Doxorubicin—prostate cancer	2.38e-05	0.000215	CcSEcCtD
Carmustine—Anaemia—Epirubicin—prostate cancer	2.38e-05	0.000215	CcSEcCtD
Carmustine—GSR—Metabolism—NCOA1—prostate cancer	2.38e-05	0.000329	CbGpPWpGaD
Carmustine—Agitation—Epirubicin—prostate cancer	2.37e-05	0.000214	CcSEcCtD
Carmustine—Rash—Etoposide—prostate cancer	2.36e-05	0.000214	CcSEcCtD
Carmustine—Dermatitis—Etoposide—prostate cancer	2.36e-05	0.000213	CcSEcCtD
Carmustine—Headache—Etoposide—prostate cancer	2.35e-05	0.000212	CcSEcCtD
Carmustine—GSR—Metabolism—CYP19A1—prostate cancer	2.34e-05	0.000324	CbGpPWpGaD
Carmustine—Decreased appetite—Prednisone—prostate cancer	2.33e-05	0.000211	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—prostate cancer	2.32e-05	0.000321	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—HPGDS—prostate cancer	2.32e-05	0.000321	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP2C19—prostate cancer	2.31e-05	0.000319	CbGpPWpGaD
Carmustine—Leukopenia—Epirubicin—prostate cancer	2.3e-05	0.000208	CcSEcCtD
Carmustine—Back pain—Doxorubicin—prostate cancer	2.3e-05	0.000208	CcSEcCtD
Carmustine—Constipation—Prednisone—prostate cancer	2.3e-05	0.000208	CcSEcCtD
Carmustine—Hypersensitivity—Docetaxel—prostate cancer	2.29e-05	0.000207	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2C19—prostate cancer	2.27e-05	0.000314	CbGpPWpGaD
Carmustine—GSR—Metabolism—RXRA—prostate cancer	2.26e-05	0.000313	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTT1—prostate cancer	2.25e-05	0.000311	CbGpPWpGaD
Carmustine—Vision blurred—Doxorubicin—prostate cancer	2.24e-05	0.000203	CcSEcCtD
Carmustine—Asthenia—Docetaxel—prostate cancer	2.23e-05	0.000202	CcSEcCtD
Carmustine—Convulsion—Epirubicin—prostate cancer	2.23e-05	0.000202	CcSEcCtD
Carmustine—Nausea—Etoposide—prostate cancer	2.23e-05	0.000201	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP2A6—prostate cancer	2.22e-05	0.000307	CbGpPWpGaD
Carmustine—Hypertension—Epirubicin—prostate cancer	2.22e-05	0.000201	CcSEcCtD
Carmustine—Hypersensitivity—Capecitabine—prostate cancer	2.22e-05	0.000201	CcSEcCtD
Carmustine—Feeling abnormal—Prednisone—prostate cancer	2.21e-05	0.0002	CcSEcCtD
Carmustine—Anaemia—Doxorubicin—prostate cancer	2.2e-05	0.000199	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—prostate cancer	2.2e-05	0.000304	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—prostate cancer	2.2e-05	0.000304	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Prednisone—prostate cancer	2.2e-05	0.000199	CcSEcCtD
Carmustine—Chest pain—Epirubicin—prostate cancer	2.19e-05	0.000198	CcSEcCtD
Carmustine—Myalgia—Epirubicin—prostate cancer	2.19e-05	0.000198	CcSEcCtD
Carmustine—Agitation—Doxorubicin—prostate cancer	2.19e-05	0.000198	CcSEcCtD
Carmustine—Anxiety—Epirubicin—prostate cancer	2.18e-05	0.000197	CcSEcCtD
Carmustine—GSR—Metabolism—COMT—prostate cancer	2.18e-05	0.000301	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—prostate cancer	2.17e-05	0.0003	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTP1—prostate cancer	2.17e-05	0.0003	CbGpPWpGaD
Carmustine—Asthenia—Capecitabine—prostate cancer	2.16e-05	0.000196	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—prostate cancer	2.15e-05	0.000297	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	2.15e-05	0.000297	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—AKR1C3—prostate cancer	2.13e-05	0.000295	CbGpPWpGaD
Carmustine—GSR—Metabolism—ITPR1—prostate cancer	2.13e-05	0.000295	CbGpPWpGaD
Carmustine—Leukopenia—Doxorubicin—prostate cancer	2.13e-05	0.000193	CcSEcCtD
Carmustine—Diarrhoea—Docetaxel—prostate cancer	2.13e-05	0.000193	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP17A1—prostate cancer	2.13e-05	0.000294	CbGpPWpGaD
Carmustine—Body temperature increased—Prednisone—prostate cancer	2.12e-05	0.000192	CcSEcCtD
Carmustine—Abdominal pain—Prednisone—prostate cancer	2.12e-05	0.000192	CcSEcCtD
Carmustine—Confusional state—Epirubicin—prostate cancer	2.12e-05	0.000192	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP17A1—prostate cancer	2.1e-05	0.00029	CbGpPWpGaD
Carmustine—Oedema—Epirubicin—prostate cancer	2.1e-05	0.00019	CcSEcCtD
Carmustine—Infection—Epirubicin—prostate cancer	2.09e-05	0.000189	CcSEcCtD
Carmustine—Convulsion—Doxorubicin—prostate cancer	2.06e-05	0.000187	CcSEcCtD
Carmustine—Diarrhoea—Capecitabine—prostate cancer	2.06e-05	0.000187	CcSEcCtD
Carmustine—Dizziness—Docetaxel—prostate cancer	2.06e-05	0.000186	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—prostate cancer	2.06e-05	0.000186	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—prostate cancer	2.06e-05	0.000186	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—prostate cancer	2.05e-05	0.000185	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	2.03e-05	0.000281	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	2.03e-05	0.000281	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	2.03e-05	0.000281	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—NCOA2—prostate cancer	2.03e-05	0.000281	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—prostate cancer	2.03e-05	0.00028	CbGpPWpGaD
Carmustine—Myalgia—Doxorubicin—prostate cancer	2.03e-05	0.000183	CcSEcCtD
Carmustine—Chest pain—Doxorubicin—prostate cancer	2.03e-05	0.000183	CcSEcCtD
Carmustine—Anxiety—Doxorubicin—prostate cancer	2.02e-05	0.000183	CcSEcCtD
Carmustine—GSR—Metabolism—TYMS—prostate cancer	2.02e-05	0.000279	CbGpPWpGaD
Carmustine—Anorexia—Epirubicin—prostate cancer	2e-05	0.000181	CcSEcCtD
Carmustine—Dizziness—Capecitabine—prostate cancer	1.99e-05	0.00018	CcSEcCtD
Carmustine—GSR—Metabolism—GSTM1—prostate cancer	1.99e-05	0.000275	CbGpPWpGaD
Carmustine—Vomiting—Docetaxel—prostate cancer	1.98e-05	0.000179	CcSEcCtD
Carmustine—Hypersensitivity—Prednisone—prostate cancer	1.98e-05	0.000179	CcSEcCtD
Carmustine—Rash—Docetaxel—prostate cancer	1.96e-05	0.000178	CcSEcCtD
Carmustine—Hypotension—Epirubicin—prostate cancer	1.96e-05	0.000177	CcSEcCtD
Carmustine—Dermatitis—Docetaxel—prostate cancer	1.96e-05	0.000177	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—prostate cancer	1.96e-05	0.000177	CcSEcCtD
Carmustine—GSR—Metabolism—LPL—prostate cancer	1.96e-05	0.00027	CbGpPWpGaD
Carmustine—Headache—Docetaxel—prostate cancer	1.95e-05	0.000176	CcSEcCtD
Carmustine—Oedema—Doxorubicin—prostate cancer	1.94e-05	0.000176	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	1.94e-05	0.000268	CbGpPWpGaD
Carmustine—Infection—Doxorubicin—prostate cancer	1.93e-05	0.000175	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—prostate cancer	1.93e-05	0.000267	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—prostate cancer	1.93e-05	0.000267	CbGpPWpGaD
Carmustine—Asthenia—Prednisone—prostate cancer	1.93e-05	0.000174	CcSEcCtD
Carmustine—Vomiting—Capecitabine—prostate cancer	1.92e-05	0.000173	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.91e-05	0.000173	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—prostate cancer	1.9e-05	0.000172	CcSEcCtD
Carmustine—Rash—Capecitabine—prostate cancer	1.9e-05	0.000172	CcSEcCtD
Carmustine—Insomnia—Epirubicin—prostate cancer	1.9e-05	0.000172	CcSEcCtD
Carmustine—Dermatitis—Capecitabine—prostate cancer	1.9e-05	0.000172	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—prostate cancer	1.9e-05	0.000172	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP2E1—prostate cancer	1.89e-05	0.000261	CbGpPWpGaD
Carmustine—Headache—Capecitabine—prostate cancer	1.89e-05	0.000171	CcSEcCtD
Carmustine—GSR—Metabolism—CYP1A1—prostate cancer	1.89e-05	0.000261	CbGpPWpGaD
Carmustine—Paraesthesia—Epirubicin—prostate cancer	1.89e-05	0.000171	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—prostate cancer	1.88e-05	0.000259	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—prostate cancer	1.88e-05	0.000259	CbGpPWpGaD
Carmustine—Dyspnoea—Epirubicin—prostate cancer	1.87e-05	0.000169	CcSEcCtD
Carmustine—GSR—Metabolism—ERCC2—prostate cancer	1.87e-05	0.000259	CbGpPWpGaD
Carmustine—Somnolence—Epirubicin—prostate cancer	1.87e-05	0.000169	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2E1—prostate cancer	1.87e-05	0.000258	CbGpPWpGaD
Carmustine—Anorexia—Doxorubicin—prostate cancer	1.85e-05	0.000168	CcSEcCtD
Carmustine—Nausea—Docetaxel—prostate cancer	1.85e-05	0.000167	CcSEcCtD
Carmustine—Diarrhoea—Prednisone—prostate cancer	1.84e-05	0.000166	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—prostate cancer	1.83e-05	0.000253	CbGpPWpGaD
Carmustine—Decreased appetite—Epirubicin—prostate cancer	1.83e-05	0.000165	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP3A4—prostate cancer	1.82e-05	0.000252	CbGpPWpGaD
Carmustine—Hypotension—Doxorubicin—prostate cancer	1.82e-05	0.000164	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.81e-05	0.000164	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP3A4—prostate cancer	1.8e-05	0.000249	CbGpPWpGaD
Carmustine—Constipation—Epirubicin—prostate cancer	1.8e-05	0.000162	CcSEcCtD
Carmustine—Pain—Epirubicin—prostate cancer	1.8e-05	0.000162	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP1B1—prostate cancer	1.79e-05	0.000248	CbGpPWpGaD
Carmustine—Nausea—Capecitabine—prostate cancer	1.79e-05	0.000162	CcSEcCtD
Carmustine—Dizziness—Prednisone—prostate cancer	1.78e-05	0.000161	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.77e-05	0.00016	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1B1—prostate cancer	1.77e-05	0.000244	CbGpPWpGaD
Carmustine—GSR—Metabolism—MTHFR—prostate cancer	1.76e-05	0.000243	CbGpPWpGaD
Carmustine—Insomnia—Doxorubicin—prostate cancer	1.76e-05	0.000159	CcSEcCtD
Carmustine—Paraesthesia—Doxorubicin—prostate cancer	1.75e-05	0.000158	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GGT1—prostate cancer	1.74e-05	0.00024	CbGpPWpGaD
Carmustine—Dyspnoea—Doxorubicin—prostate cancer	1.73e-05	0.000157	CcSEcCtD
Carmustine—Feeling abnormal—Epirubicin—prostate cancer	1.73e-05	0.000157	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	1.73e-05	0.000239	CbGpPWpGaD
Carmustine—Somnolence—Doxorubicin—prostate cancer	1.73e-05	0.000156	CcSEcCtD
Carmustine—GSR—Metabolism—PPARA—prostate cancer	1.73e-05	0.000239	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Epirubicin—prostate cancer	1.72e-05	0.000155	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—NCOA1—prostate cancer	1.71e-05	0.000236	CbGpPWpGaD
Carmustine—Vomiting—Prednisone—prostate cancer	1.71e-05	0.000154	CcSEcCtD
Carmustine—Rash—Prednisone—prostate cancer	1.69e-05	0.000153	CcSEcCtD
Carmustine—Dermatitis—Prednisone—prostate cancer	1.69e-05	0.000153	CcSEcCtD
Carmustine—Decreased appetite—Doxorubicin—prostate cancer	1.69e-05	0.000153	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP19A1—prostate cancer	1.69e-05	0.000233	CbGpPWpGaD
Carmustine—Headache—Prednisone—prostate cancer	1.68e-05	0.000152	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—prostate cancer	1.68e-05	0.000233	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—prostate cancer	1.68e-05	0.000232	CbGpPWpGaD
Carmustine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.68e-05	0.000152	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP19A1—prostate cancer	1.66e-05	0.00023	CbGpPWpGaD
Carmustine—Constipation—Doxorubicin—prostate cancer	1.66e-05	0.00015	CcSEcCtD
Carmustine—Pain—Doxorubicin—prostate cancer	1.66e-05	0.00015	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—prostate cancer	1.66e-05	0.00015	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—prostate cancer	1.66e-05	0.00015	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—prostate cancer	1.65e-05	0.000227	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—prostate cancer	1.65e-05	0.000227	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—RXRA—prostate cancer	1.63e-05	0.000225	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	1.63e-05	0.000225	CbGpPWpGaD
Carmustine—GSR—Metabolism—CAV1—prostate cancer	1.62e-05	0.000224	CbGpPWpGaD
Carmustine—Feeling abnormal—Doxorubicin—prostate cancer	1.6e-05	0.000145	CcSEcCtD
Carmustine—Nausea—Prednisone—prostate cancer	1.6e-05	0.000144	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.59e-05	0.000144	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	1.58e-05	0.000219	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—COMT—prostate cancer	1.57e-05	0.000217	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTP1—prostate cancer	1.56e-05	0.000216	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—prostate cancer	1.55e-05	0.000215	CbGpPWpGaD
Carmustine—Hypersensitivity—Epirubicin—prostate cancer	1.55e-05	0.00014	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—COMT—prostate cancer	1.55e-05	0.000214	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	1.54e-05	0.000213	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTP1—prostate cancer	1.54e-05	0.000213	CbGpPWpGaD
Carmustine—Body temperature increased—Doxorubicin—prostate cancer	1.54e-05	0.000139	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—prostate cancer	1.54e-05	0.000139	CcSEcCtD
Carmustine—Asthenia—Epirubicin—prostate cancer	1.51e-05	0.000136	CcSEcCtD
Carmustine—GSR—Metabolism—PIK3CG—prostate cancer	1.48e-05	0.000204	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	1.47e-05	0.000203	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	1.47e-05	0.000203	CbGpPWpGaD
Carmustine—Diarrhoea—Epirubicin—prostate cancer	1.44e-05	0.00013	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTM1—prostate cancer	1.43e-05	0.000198	CbGpPWpGaD
Carmustine—Hypersensitivity—Doxorubicin—prostate cancer	1.43e-05	0.000129	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—GSTM1—prostate cancer	1.41e-05	0.000195	CbGpPWpGaD
Carmustine—GSR—Metabolism—INS—prostate cancer	1.4e-05	0.000194	CbGpPWpGaD
Carmustine—Asthenia—Doxorubicin—prostate cancer	1.39e-05	0.000126	CcSEcCtD
Carmustine—Dizziness—Epirubicin—prostate cancer	1.39e-05	0.000126	CcSEcCtD
Carmustine—GSR—Metabolism—CREBBP—prostate cancer	1.37e-05	0.00019	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP1A1—prostate cancer	1.36e-05	0.000188	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HAO1—prostate cancer	1.34e-05	0.000185	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1A1—prostate cancer	1.34e-05	0.000185	CbGpPWpGaD
Carmustine—Vomiting—Epirubicin—prostate cancer	1.34e-05	0.000121	CcSEcCtD
Carmustine—Diarrhoea—Doxorubicin—prostate cancer	1.33e-05	0.00012	CcSEcCtD
Carmustine—Rash—Epirubicin—prostate cancer	1.32e-05	0.00012	CcSEcCtD
Carmustine—Dermatitis—Epirubicin—prostate cancer	1.32e-05	0.00012	CcSEcCtD
Carmustine—Headache—Epirubicin—prostate cancer	1.32e-05	0.000119	CcSEcCtD
Carmustine—GSR—Metabolism—PIK3CD—prostate cancer	1.3e-05	0.00018	CbGpPWpGaD
Carmustine—Dizziness—Doxorubicin—prostate cancer	1.29e-05	0.000116	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	1.25e-05	0.000173	CbGpPWpGaD
Carmustine—Nausea—Epirubicin—prostate cancer	1.25e-05	0.000113	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—prostate cancer	1.24e-05	0.000112	CcSEcCtD
Carmustine—GSR—Metabolism—NOS3—prostate cancer	1.23e-05	0.00017	CbGpPWpGaD
Carmustine—Rash—Doxorubicin—prostate cancer	1.23e-05	0.000111	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—prostate cancer	1.22e-05	0.000111	CcSEcCtD
Carmustine—Headache—Doxorubicin—prostate cancer	1.22e-05	0.00011	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	1.2e-05	0.000166	CbGpPWpGaD
Carmustine—Nausea—Doxorubicin—prostate cancer	1.15e-05	0.000104	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	1.15e-05	0.00016	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CB—prostate cancer	1.13e-05	0.000157	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS2—prostate cancer	1.12e-05	0.000155	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	1.11e-05	0.000154	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GRHL1—prostate cancer	1.09e-05	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ADI1—prostate cancer	1.09e-05	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CSAD—prostate cancer	1.09e-05	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TST—prostate cancer	1.09e-05	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PSAT1—prostate cancer	1.09e-05	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CBR1—prostate cancer	1.09e-05	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	1.07e-05	0.000148	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	1.05e-05	0.000145	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UGT2B15—prostate cancer	1.02e-05	0.00014	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CKMT2—prostate cancer	1.02e-05	0.00014	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UGT2B17—prostate cancer	1.02e-05	0.00014	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GRHPR—prostate cancer	1.02e-05	0.00014	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	9.93e-06	0.000137	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTEN—prostate cancer	9.79e-06	0.000135	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	9.77e-06	0.000135	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTM3—prostate cancer	9.56e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SULT2B1—prostate cancer	9.56e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AOX1—prostate cancer	9.56e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PGAM2—prostate cancer	9.56e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NAGLU—prostate cancer	9.56e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—RFK—prostate cancer	9.56e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MBTPS1—prostate cancer	9.56e-06	0.000132	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	9.34e-06	0.000129	CbGpPWpGaD
Carmustine—GSR—Metabolism—EP300—prostate cancer	9.34e-06	0.000129	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AMACR—prostate cancer	9.06e-06	0.000125	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP3A43—prostate cancer	9.06e-06	0.000125	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—DEGS1—prostate cancer	9.06e-06	0.000125	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SRD5A2—prostate cancer	9.06e-06	0.000125	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NAT1—prostate cancer	9.06e-06	0.000125	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	8.91e-06	0.000123	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	8.85e-06	0.000122	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSD17B1—prostate cancer	8.64e-06	0.000119	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	8.64e-06	0.000119	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	8.31e-06	0.000115	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	8.27e-06	0.000114	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	8.18e-06	0.000113	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	7.8e-06	0.000108	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—B4GALT4—prostate cancer	7.7e-06	0.000106	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HPGD—prostate cancer	7.7e-06	0.000106	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TNFRSF21—prostate cancer	7.24e-06	0.0001	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP7B1—prostate cancer	7.05e-06	9.74e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTAP—prostate cancer	7.05e-06	9.74e-05	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CA—prostate cancer	6.91e-06	9.55e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	6.89e-06	9.52e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SULT1E1—prostate cancer	6.87e-06	9.49e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SRD5A1—prostate cancer	6.87e-06	9.49e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	6.67e-06	9.22e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	6.57e-06	9.08e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ACSL4—prostate cancer	6.55e-06	9.05e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSD17B3—prostate cancer	6.55e-06	9.05e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	6.47e-06	8.95e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ARG2—prostate cancer	6.28e-06	8.68e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PHGDH—prostate cancer	6.28e-06	8.68e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UMPS—prostate cancer	6.28e-06	8.68e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	6.25e-06	8.64e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LDHB—prostate cancer	6.16e-06	8.51e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP3A5—prostate cancer	6.04e-06	8.35e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TCN2—prostate cancer	5.84e-06	8.07e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PDHA1—prostate cancer	5.84e-06	8.07e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA3—prostate cancer	5.84e-06	8.07e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UCP3—prostate cancer	5.84e-06	8.07e-05	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—prostate cancer	5.64e-06	7.8e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSD3B1—prostate cancer	5.57e-06	7.7e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC22A3—prostate cancer	5.57e-06	7.7e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	5.4e-06	7.47e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TBXAS1—prostate cancer	5.34e-06	7.38e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA4—prostate cancer	5.34e-06	7.38e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.22e-06	7.21e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA2—prostate cancer	5.2e-06	7.19e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SULT1A1—prostate cancer	5.14e-06	7.1e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCG5—prostate cancer	5.14e-06	7.1e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA1—prostate cancer	5.02e-06	6.94e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NAT2—prostate cancer	4.96e-06	6.86e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTO1—prostate cancer	4.96e-06	6.86e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSD3B2—prostate cancer	4.96e-06	6.86e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.77e-06	6.6e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PLCB2—prostate cancer	4.76e-06	6.58e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2C18—prostate cancer	4.76e-06	6.58e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LRP2—prostate cancer	4.76e-06	6.58e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—P4HB—prostate cancer	4.67e-06	6.45e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC22A1—prostate cancer	4.54e-06	6.28e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.49e-06	6.2e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SULT2A1—prostate cancer	4.42e-06	6.12e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MED12—prostate cancer	4.35e-06	6.02e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GNG5—prostate cancer	4.32e-06	5.97e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOA3—prostate cancer	4.16e-06	5.75e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.09e-06	5.65e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HPGDS—prostate cancer	3.97e-06	5.48e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.94e-06	5.45e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTT1—prostate cancer	3.85e-06	5.32e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ACHE—prostate cancer	3.85e-06	5.32e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.8e-06	5.26e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.79e-06	5.24e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.7e-06	5.12e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PRKACB—prostate cancer	3.68e-06	5.09e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP17A1—prostate cancer	3.64e-06	5.04e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.59e-06	4.97e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOA2—prostate cancer	3.47e-06	4.8e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.31e-06	4.58e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.23e-06	4.47e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NQO1—prostate cancer	3.2e-06	4.42e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TH—prostate cancer	3.15e-06	4.36e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.13e-06	4.33e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.12e-06	4.31e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.1e-06	4.29e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.07e-06	4.24e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GGT1—prostate cancer	2.97e-06	4.11e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOA1—prostate cancer	2.93e-06	4.04e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.88e-06	3.99e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—RXRA—prostate cancer	2.78e-06	3.85e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.71e-06	3.74e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—COMT—prostate cancer	2.68e-06	3.7e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTP1—prostate cancer	2.67e-06	3.69e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ITPR1—prostate cancer	2.63e-06	3.63e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.58e-06	3.57e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TYMS—prostate cancer	2.48e-06	3.43e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTM1—prostate cancer	2.45e-06	3.39e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—LPL—prostate cancer	2.41e-06	3.33e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.32e-06	3.21e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ERCC2—prostate cancer	2.3e-06	3.19e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTHFR—prostate cancer	2.17e-06	2.99e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARA—prostate cancer	2.13e-06	2.94e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CAV1—prostate cancer	2e-06	2.76e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.91e-06	2.64e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.82e-06	2.52e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—INS—prostate cancer	1.72e-06	2.38e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.69e-06	2.33e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.6e-06	2.21e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NOS3—prostate cancer	1.51e-06	2.09e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.39e-06	1.93e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTEN—prostate cancer	1.21e-06	1.67e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—EP300—prostate cancer	1.15e-06	1.59e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.5e-07	1.18e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—prostate cancer	6.95e-07	9.6e-06	CbGpPWpGaD
